Atrial Fibrillation and Other Clinical Manifestations of Altered TBX5 Dosage in Typical Holt-Oram Syndrome

Documenti analoghi

• Expressivity of Holt-Oram Syndrome Is Not Predicted by TBX5 Genotype
  di: Brassington, Anna-Marie E., et al.
  Pubblicazione: (2003)
• Different TBX5 interactions in heart and limb defined by Holt–Oram syndrome mutations
  di: Basson, Craig T., et al.
  Pubblicazione: (1999)
• Novel TBX5 mutations and molecular mechanism for Holt-Oram syndrome
  di: Fan, C, et al.
  Pubblicazione: (2003)
• Novel mutations in the TBX5 gene in patients with Holt-Oram Syndrome
  di: Porto, Marianna P. R., et al.
  Pubblicazione: (2010)
• Functional Analysis of TBX5 Missense Mutations Associated with Holt-Oram Syndrome
  di: Fan, Chun, et al.
  Pubblicazione: (2002)